Перейти к информации о продукте
1 из 1

Pazorest 200 mg (Pazopanib 200 mg (as pazopanib hydrochloride))

Pazorest 200 mg (Pazopanib 200 mg (as pazopanib hydrochloride))

Просмотреть всю информацию
Packaging Size: 28 tablets
Strength: 200 mg
Composition: Pazopanib 200 mg (as pazopanib hydrochloride)
Treatment: Used for advanced renal cell carcinoma (RCC) and certain advanced soft-tissue sarcomas (STS) following prior chemotherapy
Form: Film-coated tablet for oral use
Brand: Pazorest 200 mg
Quantity Unit: Tablet
Manufacturer: Everest Pharmaceuticals Ltd.

Pazorest 200 mg (Pazopanib) is a targeted anticancer medicine belonging to the tyrosine kinase inhibitor (TKI) class. It works by blocking specific proteins involved in tumor growth and the formation of new blood vessels that supply cancer cells. It is mainly used to treat advanced renal cell carcinoma (kidney cancer) and certain advanced soft-tissue sarcomas. It should be used under the supervision of an oncologist.



Everyone Deserves Access to Life-saving Treatment Of Cancer. We are a Trusted Cancer Medicine seller delivering certified medications to every corner of the world.